Estados Unidos · Agencias y tiempo real · PR Newswire

New clinical data on lecanemab to be presented at CTAD conference 2026

Publicado por PR Newswire · Estados Unidos hace 1 h

STOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab…

Leer el artículo completo en PR Newswire Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.prnewswire.com)

New clinical data on lecanemab to be presented at CTAD conference 2026

También te puede interesar

What to consider if a company that made AI-related job cuts wants you back

Eagle Point Provides Strategic Equipment Financing to Energy Vault for Behind the Meter Power Infrastructure

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

New clinical data on lecanemab to be presented at CTAD conference 2026

Compartir

También te puede interesar

What to consider if a company that made AI-related job cuts wants you back

Eagle Point Provides Strategic Equipment Financing to Energy Vault for Behind the Meter Power Infrastructure

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows